Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 6, 2014, 103 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $555.82 to $40,491,464.00.

Highlighted Stocks Traded by Insiders:

Cell Therapeutics (CTIC) - FREE Research Report

Plunkett Matthew, who is EVP, Corporate Development at Cell Therapeutics, sold 12,000 shares at $2.39 on Nov. 6, 2014. Following this transaction, the EVP, Corporate Development owned 417,968 shares meaning that the stake was reduced by 2.79% with the 12,000-share transaction.

The shares most recently traded at $3.01, up $0.62, or 20.64% since the insider transaction. Historical insider transactions for Cell Therapeutics go as follows:

  • 4-Week # shares sold: 12,000
  • 12-Week # shares sold: 635,004
  • 24-Week # shares sold: 796,004

The average volume for Cell Therapeutics has been 3.7 million shares per day over the past 30 days. Cell Therapeutics has a market cap of $440.5 million and is part of the health care sector and drugs industry. Shares are up 53.93% year-to-date as of the close of trading on Tuesday.

CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer.

Exclusive Offer: Get the latest Stock Analysis on CTIC - FREE

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Boston Beer (SAM) - FREE Research Report

Wade Kathleen H, who is VP - Legal and Secretary at Boston Beer, sold 1,250 shares at $251.04 on Nov. 6, 2014. Following this transaction, the VP - Legal and Secretary owned 9,391 shares meaning that the stake was reduced by 11.75% with the 1,250-share transaction.

The shares most recently traded at $255.65, up $4.61, or 1.8% since the insider transaction. Historical insider transactions for Boston Beer go as follows:

  • 4-Week # shares bought: 205
  • 4-Week # shares sold: 2,000
  • 12-Week # shares bought: 205
  • 12-Week # shares sold: 2,000
  • 24-Week # shares bought: 205
  • 24-Week # shares sold: 65,038

The average volume for Boston Beer has been 49,900 shares per day over the past 30 days. Boston Beer has a market cap of $2.4 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 6.89% year-to-date as of the close of trading on Thursday.

The Boston Beer Company, Inc. produces and sells alcohol beverages primarily in the United States, Canada, Europe, Israel, the Caribbean, the Pacific Rim, Mexico, and Central and South America. The company has a P/E ratio of 38.1. Currently, there are 2 analysts who rate Boston Beer a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on SAM - FREE

TheStreet Quant Ratings

rates Boston Beer as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

Boston Beer Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

DigitalGlobe (DGI) - FREE Research Report

Turner David B. Jr., who is SVP, Sales & Marketing at DigitalGlobe, sold 3,000 shares at $28.84 on Nov. 6, 2014. Following this transaction, the SVP, Sales & Marketing owned 36,876 shares meaning that the stake was reduced by 7.52% with the 3,000-share transaction.

The shares most recently traded at $28.65, down $0.19, or 0.67% since the insider transaction. Historical insider transactions for DigitalGlobe go as follows:

  • 4-Week # shares bought: 3,000
  • 4-Week # shares sold: 15,000
  • 12-Week # shares bought: 3,000
  • 12-Week # shares sold: 15,000
  • 24-Week # shares bought: 3,000
  • 24-Week # shares sold: 26,500

The average volume for DigitalGlobe has been 467,900 shares per day over the past 30 days. DigitalGlobe has a market cap of $2.1 billion and is part of the industrial goods sector and aerospace/defense industry. Shares are down 30.16% year-to-date as of the close of trading on Thursday.

DigitalGlobe, Inc. provides imagery and imagery information products and services in the United States and internationally. The company has a P/E ratio of 114.1. Currently, there are 6 analysts who rate DigitalGlobe a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on DGI - FREE

TheStreet Quant Ratings

rates DigitalGlobe as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income and good cash flow from operations. However, as a counter to these strengths, we find that the stock has experienced relatively poor performance when compared with the S&P 500 during the past year. Get the full

DigitalGlobe Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null